DYN
Price
$18.21
Change
-$0.21 (-1.14%)
Updated
Sep 11 closing price
Capitalization
3.4B
47 days until earnings call
Intraday BUY SELL Signals
VNDA
Price
$5.09
Change
+$0.05 (+0.99%)
Updated
Sep 11 closing price
Capitalization
307.15M
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs VNDA

DYN vs VNDA Comparison Chart in %
View a ticker or compare two or three
VS
DYN vs. VNDA commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Buy and VNDA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($3.4B) has a higher market cap than VNDA($307M). DYN YTD gains are higher at: -6.902 vs. VNDA (-42.290). VNDA has higher annual earnings (EBITDA): -172.24M vs. DYN (-502.36M). DYN has more cash in the bank: 898M vs. VNDA (170M). VNDA has less debt than DYN: VNDA (22.8M) vs DYN (219M). VNDA has higher revenues than DYN: VNDA (216M) vs DYN (0).
DYNVNDADYN / VNDA
Capitalization3.4B307M1,109%
EBITDA-502.36M-172.24M292%
Gain YTD-6.902-42.29016%
P/E RatioN/A126.00-
Revenue0216M-
Total Cash898M170M528%
Total Debt219M22.8M961%
FUNDAMENTALS RATINGS
DYN vs VNDA: Fundamental Ratings
DYN
VNDA
OUTLOOK RATING
1..100
5130
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6162
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
2425

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DYN's Valuation (36) in the Electric Utilities industry is somewhat better than the same rating for VNDA (93) in the Biotechnology industry. This means that DYN’s stock grew somewhat faster than VNDA’s over the last 12 months.

DYN's Profit vs Risk Rating (97) in the Electric Utilities industry is in the same range as VNDA (100) in the Biotechnology industry. This means that DYN’s stock grew similarly to VNDA’s over the last 12 months.

DYN's SMR Rating (98) in the Electric Utilities industry is in the same range as VNDA (98) in the Biotechnology industry. This means that DYN’s stock grew similarly to VNDA’s over the last 12 months.

DYN's Price Growth Rating (61) in the Electric Utilities industry is in the same range as VNDA (62) in the Biotechnology industry. This means that DYN’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for DYN (100) in the Electric Utilities industry. This means that VNDA’s stock grew significantly faster than DYN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DYNVNDA
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
Bullish Trend 11 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 3 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (DYN: $18.21 vs. VNDA: $5.09)
Brand notoriety: DYN and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 148% vs. VNDA: 63%
Market capitalization -- DYN: $3.4B vs. VNDA: $307.15M
DYN [@Biotechnology] is valued at $3.4B. VNDA’s [@Biotechnology] market capitalization is $307.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 0 FA rating(s) are green while VNDA’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both DYN and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 6 bearish.
  • VNDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VNDA is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а -25.00% price change this week, while VNDA (@Biotechnology) price change was -6.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

DYN is expected to report earnings on Oct 29, 2026.

VNDA is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DYN
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PJFV100.941.31
+1.32%
PGIM Jennison Focused Value ETF
INDY42.510.38
+0.90%
iShares India 50 ETF
PZA22.120.06
+0.27%
Invesco National AMT-Free Muni Bd ETF
PBFB32.460.08
+0.25%
PGIM S&P 500 Buffer 20 ETF - Feb
UBEW24.98-0.37
-1.45%
Roundhill UBER WeeklyPay ETF

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-1.14%
RNA - DYN
64%
Loosely correlated
+0.10%
RCKT - DYN
47%
Loosely correlated
-3.74%
BBIO - DYN
46%
Loosely correlated
-0.08%
IDYA - DYN
45%
Loosely correlated
+0.37%
CLDX - DYN
45%
Loosely correlated
-3.15%
More